Advanced Cancer
Showing NaN - NaN of 101
Advanced Cancer Trial in Houston (Interactive Voice Response System, Standard Care)
Active, not recruiting
- Advanced Cancer
- Interactive Voice Response System
- Standard Care
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 9, 2022
Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)
Recruiting
- Urothelial Carcinoma
- +20 more
- IK-175
- IK-175 and nivolumab
-
Gilbert, Arizona
- +9 more
Feb 3, 2022
Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)
Recruiting
- Advanced Cancer
- +9 more
- COM701
- COM701 with Opdivo (Nivolumab).
-
Los Angeles, California
- +10 more
Jan 25, 2022
Advanced Cancer Trial in Houston (FLT-PET)
Completed
- Advanced Cancer
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 3, 2022
Solid Tumor, Adult, Advanced Solid Tumor, Advanced Cancer Trial in United States (MPT-0118, MPT-0118 + pembrolizumab)
Recruiting
- Solid Tumor, Adult
- +4 more
- MPT-0118
- MPT-0118 + pembrolizumab
-
Santa Monica, California
- +4 more
Sep 15, 2021
Advanced Cancer, Metastatic Melanoma, Metastatic NSCLC Trial in Worldwide (LY3214996, Midazolam, Abemaciclib)
Active, not recruiting
- Advanced Cancer
- +3 more
- LY3214996
- +6 more
-
Washington, District of Columbia
- +12 more
Sep 2, 2021
Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Gastric Cancer Trial in Worldwide (177Lu-3BP-227 (also called
Terminated
- Pancreatic Ductal Adenocarcinoma
- +7 more
- 177Lu-3BP-227 (also called 177Lu-IPN01087)
-
Houston, Texas
- +7 more
Jun 2, 2021
Psychophysical Studies of Cancer Therapy Pain
Recruiting
- Advanced Cancer
- Pain
- Sensory Tests
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 31, 2021
Solid Tumors, Advanced Cancer Trial in Houston (Anastrozole, Bevacizumab, Everolimus)
Completed
- Solid Tumors
- Advanced Cancer
- Anastrozole
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 20, 2021
Malignant Tumors of Independent (Primary) Multiple Sites, Advanced Cancer Trial in Houston (Baseline Questionnaires, Videos,
Completed
- Malignant Neoplasms of Independent (Primary) Multiple Sites
- Advanced Cancer
- Baseline Questionnaires
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 23, 2020
Caregiver Assessments of the Quality of Home Hospice Care
Terminated
- Advanced Cancer
- Phone Interview/Questionnaire
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 27, 2020
Advanced Cancer Trial in Houston (Bevacizumab, Sorafenib, Erlotinib)
Completed
- Advanced Cancer
- Bevacizumab
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 27, 2020
Advanced Cancer, Solid Tumor Trial in Houston (Vemurafenib, Everolimus, Temsirolimus)
Completed
- Advanced Cancer
- Solid Tumor
- Vemurafenib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 1, 2020
Advanced Cancer Trial in Houston (Sirolimus, Vorinostat, Everolimus)
Unknown status
- Advanced Cancer
- Sirolimus
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 10, 2020
Advanced Cancer, Advanced Malignancies Trial in Australia, Spain, United States (Cemiplimab, Hypofractionated radiotherapy,
Completed
- Advanced Cancer
- Advanced Malignancies
- Cemiplimab
- +7 more
-
Gilbert, Arizona
- +46 more
Jan 23, 2020
Spirituality/Religiosity in Patients and Caregivers
Unknown status
- Advanced Cancer
- Solid Tumors
- Questionnaires
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 10, 2019